Stories by Amy Maxmen

Neural networks are making biological images easier to process

Analyses of governing documents from 194 countries could help people fighting for human and environmental rights

Success for the “Arctic apple” could herald a new wave of lab-grown foods

Aid organizations have been piloting a nimble approach to cut through the fog of war

Researchers are seeking approval from regulators for this quicker, easier treatment

Ecologists catalogue bird and mammal populations as warming transforms Death Valley

When forced to compete for mates, some birds develop longer penises and others almost nothing at all

Researchers were told to censor descriptions of projects funded by a Department of Energy laboratory

Women with sleep disorders were about twice as likely to deliver babies more than six weeks early

Nonprofit group helps marshal trial of a new antibiotic in an attempt to beat back resistant infections

Finding could help researchers to better predict where these viruses are likely to make the jump from animals to people

Two research teams cook up recipe to make long-sought cells in mice and people

A difference in these trimming cells between the sexes might render males most vulnerable to the disorder

A promising treatment that uses MDMA could help people suffering with post-traumatic stress disorder 

A new study is the latest in the long-running dispute over which lineage—sponges or comb jellies—is the ancestor to all animals

The discovery may help doctors identify elusive infected cells in the body

To work out how the genome evolved, bioengineers are recreating it

The ensuing damage to scientific collaboration puts the U.S. at risk, researchers say 

John Holdren says the president’s move could strain international science ties, possibly making the world less safe  

Last-minute proposal would address CRISPR and other cutting-edge technologies

Vulnerable young women often do not to take drugs that could block infection. Doctors are trying to figure out alternatives

A nonprofit organization that creates new drugs for neglected diseases proves development doesn't have to cost a fortune. Can its model work more broadly?

Mass drug distribution was intended to curb cases with Ebola-like symptoms and reduce, in turn, the number of people whose symptoms could be mistaken for those of Ebola

A journalist on a monthlong visit to Sierra Leone provides a realistic view of people living their lives while their nation struggles to recover from a deadly outbreak